INDIA SAMUELS: Open Payments
NPI 1407283294 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 34 payments from 9 companies in 2025. Trend: 2023 $1,647 · 2024 $1,374 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $243 |
| Teva Pharmaceuticals USA, Inc. | 6 | $236 |
| ABBVIE INC. | 4 | $153 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $98 |
| Indivior Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: UZEDY, ARISTADA, VRAYLAR, SUBLOCADE, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
